India Diabetes Care Market Expected to Reach USD 21.56 Billion by 2030

India Diabetes Care Market Expected to Reach USD 21.56 Billion by 2030

Dublin, Dec. 11, 2024 (Alayaran.com) - A new market research report released by ResearchAndMarkets.com has predicted that India's diabetes care market is expected to reach USD 21.56 billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 6.18% during the forecast period.

The Indian Diabetes Care Market has shown remarkable growth in recent years, driven by the rising prevalence of diabetes and enhanced health awareness. The market represents a significant opportunity for stakeholders, but to thrive, companies will need to navigate several challenges including cost considerations, accessibility of care, and regulatory complexities.

Digital Health Solutions and Telemedicine are key trends emerging in this market. The integration of telemedicine and mobile health (mHealth) applications is enhancing patient access to healthcare services, particularly in rural and underserved areas. These technologies allow patients to consult healthcare professionals remotely, receive timely advice, and monitor their conditions without the need for frequent hospital visits.

Personalized Medicine and Data Analytics are also gaining traction in the diabetes care landscape in India. Advances in data analytics, artificial intelligence (AI), and machine learning are enabling healthcare providers to tailor treatment plans based on individual patient profiles.

In terms of regional insights, South India emerged as the dominant region in 2024, holding the largest market share in terms of value. The region boasts a well-developed healthcare infrastructure and higher levels of health awareness and education regarding diabetes management.

The key market players include Sanofi, Novo Nordisk India, USV, Novartis, Merck, Becton Dickinson and Company, F. Hoffmann-La Roche, Health Arx Technologies, and Sushant Kumar Ventures.

Overall, the report highlights the significant opportunities for growth in the Indian diabetes care market, driven by technological advancements and increased health awareness.